Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Micro Reactor Technology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111039829A enables safe continuous production of p-acetamido benzene sulfonyl chloride, offering high purity and supply chain stability for global buyers.
Novel patent CN117904246A details 7-ANCA production with reduced waste and higher yield. Offers supply chain stability and cost efficiency for antibiotic manufacturers.
Patent CN113121424A details a micro-reactor process for Palbociclib intermediates, offering superior purity, safety, and scalable manufacturing capabilities.
Patent CN113233962B reveals microchannel tech for high-purity 2,6-dihydroxytoluene. Reduces cost and improves supply chain reliability for pharma intermediates.
Patent CN106083623B reveals a safer microchannel route for 5-aminosalicylic acid. Achieve high purity and yield with reduced environmental impact for reliable supply.
Patent CN111039829B details a safe continuous flow method for producing p-acetamidobenzenesulfonyl chloride, offering high purity and reduced waste for pharmaceutical intermediates.
Patent CN115417895A reveals a safer microchannel hydrogenation process for cis-propenyl phosphoric acid, offering >97% selectivity and reduced catalyst costs for fosfomycin production.
Novel peramivir synthesis using Red-Al reduction and micro-reactor technology. Enhances yield, safety, and supply chain reliability for pharmaceutical manufacturers.
Patent CN110845337B reveals a safer microreactor bromination route for kinase inhibitor intermediates, offering superior selectivity and scalable manufacturing solutions.
Novel microreactor process for MB-301 intermediates boosts yield to 90%. Reduces toxic ammonia use. Ideal for fluorescent tracer manufacturing.
Patent CN104328150B reveals continuous enzymatic synthesis. High yield, reduced cost, reliable supply chain for pharmaceutical intermediates manufacturing.
Discover the advanced continuous flow synthesis of (3aS,6aR)-lactone per patent CN114560865A. Achieve >99% ee and >90% yield with reduced costs and enhanced supply reliability for biotin production.
Patent CN113845417A details a safer continuous flow method for naproxen intermediates. Discover cost reduction and high-purity manufacturing advantages.
Patent CN104356115B details microreactor synthesis for Avanafil intermediate ensuring high purity and supply chain stability for global pharmaceutical manufacturing partners.
Patent CN111848517B details a novel continuous flow method for Edaravone. Achieve high purity >99% and safer manufacturing. Contact us for supply.
Patent CN115286532A reveals a continuous micro-reactor method for synthesizing DL-aminopropionitrile, offering high purity and scalable manufacturing for methyldopa intermediates.
Patent CN103588662A details a novel continuous-flow method for synthesizing Betamipron, offering enhanced purity and reduced toxicity for reliable pharmaceutical intermediate supply chains.
Patent CN103588662A details a continuous-flow microreactor method for synthesizing Betamipron, offering superior purity and cost reduction in API manufacturing compared to conventional batch processes.
Novel micro-channel synthesis reduces cost and waste for chlorantraniliprole intermediates. Reliable supply chain partner for high-purity agrochemical manufacturing.
Patent CN107056766B reveals high-purity Azilsartan synthesis via microreactor. Achieve significant cost reduction in API manufacturing and supply chain reliability.